861 related articles for article (PubMed ID: 28082367)
1. Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort.
Bérard A; Zhao JP; Sheehy O
BMJ Open; 2017 Jan; 7(1):e013372. PubMed ID: 28082367
[TBL] [Abstract][Full Text] [Related]
2. Sertraline use during pregnancy and the risk of major malformations.
Bérard A; Zhao JP; Sheehy O
Am J Obstet Gynecol; 2015 Jun; 212(6):795.e1-795.e12. PubMed ID: 25637841
[TBL] [Abstract][Full Text] [Related]
3. SSRI and SNRI use during pregnancy and the risk of persistent pulmonary hypertension of the newborn.
Bérard A; Sheehy O; Zhao JP; Vinet É; Bernatsky S; Abrahamowicz M
Br J Clin Pharmacol; 2017 May; 83(5):1126-1133. PubMed ID: 27874994
[TBL] [Abstract][Full Text] [Related]
4. Antidepressant use in pregnancy and the risk of cardiac defects.
Huybrechts KF; Palmsten K; Avorn J; Cohen LS; Holmes LB; Franklin JM; Mogun H; Levin R; Kowal M; Setoguchi S; Hernández-Díaz S
N Engl J Med; 2014 Jun; 370(25):2397-407. PubMed ID: 24941178
[TBL] [Abstract][Full Text] [Related]
5. Maternal Use of Specific Antidepressant Medications During Early Pregnancy and the Risk of Selected Birth Defects.
Anderson KN; Lind JN; Simeone RM; Bobo WV; Mitchell AA; Riehle-Colarusso T; Polen KN; Reefhuis J
JAMA Psychiatry; 2020 Dec; 77(12):1246-1255. PubMed ID: 32777011
[TBL] [Abstract][Full Text] [Related]
6. Duration of antidepressant use during pregnancy and risk of major congenital malformations.
Ramos E; St-André M; Rey E; Oraichi D; Bérard A
Br J Psychiatry; 2008 May; 192(5):344-50. PubMed ID: 18450657
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of depressed pregnant women by selective serotonin reuptake inhibitors: risk for the foetus and the newborn].
Favrelière S; Nourrisson A; Jaafari N; Pérault Pochat MC
Encephale; 2010 Jun; 36 Suppl 2():D133-8. PubMed ID: 20513456
[TBL] [Abstract][Full Text] [Related]
8. Maternal depression, antidepressant prescriptions, and congenital anomaly risk in offspring: a population-based cohort study.
Ban L; Gibson JE; West J; Fiaschi L; Sokal R; Smeeth L; Doyle P; Hubbard RB; Tata LJ
BJOG; 2014 Nov; 121(12):1471-81. PubMed ID: 24612301
[TBL] [Abstract][Full Text] [Related]
9. Antidepressant use during pregnancy and the risk of gestational diabetes mellitus: a nested case-control study.
Dandjinou M; Sheehy O; Bérard A
BMJ Open; 2019 Oct; 9(9):e025908. PubMed ID: 31575566
[TBL] [Abstract][Full Text] [Related]
10. SSRI antidepressants and birth defects.
Prescrire Int; 2006 Dec; 15(86):222-3. PubMed ID: 17167929
[TBL] [Abstract][Full Text] [Related]
11. First trimester exposure to paroxetine and risk of cardiac malformations in infants: the importance of dosage.
Bérard A; Ramos E; Rey E; Blais L; St-André M; Oraichi D
Birth Defects Res B Dev Reprod Toxicol; 2007 Feb; 80(1):18-27. PubMed ID: 17187388
[TBL] [Abstract][Full Text] [Related]
12. Antidepressant use in pregnancy and severe cardiac malformations: Danish register-based study.
Kolding L; Ehrenstein V; Pedersen L; Sandager P; Petersen OB; Uldbjerg N; Pedersen LH
BJOG; 2021 Nov; 128(12):1949-1957. PubMed ID: 34036715
[TBL] [Abstract][Full Text] [Related]
13. Selective serotonin reuptake inhibitors and the risk of congenital anomalies: a systematic review of current meta-analyses.
Uguz F
Expert Opin Drug Saf; 2020 Dec; 19(12):1595-1604. PubMed ID: 33001713
[No Abstract] [Full Text] [Related]
14. Antidepressant Use During Pregnancy and the Risk of Autism Spectrum Disorder in Children.
Boukhris T; Sheehy O; Mottron L; Bérard A
JAMA Pediatr; 2016 Feb; 170(2):117-24. PubMed ID: 26660917
[TBL] [Abstract][Full Text] [Related]
15. Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: a systematic review and meta-analysis.
Eke AC; Saccone G; Berghella V
BJOG; 2016 Nov; 123(12):1900-1907. PubMed ID: 27239775
[TBL] [Abstract][Full Text] [Related]
16. Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births.
Gao SY; Wu QJ; Sun C; Zhang TN; Shen ZQ; Liu CX; Gong TT; Xu X; Ji C; Huang DH; Chang Q; Zhao YH
BMC Med; 2018 Nov; 16(1):205. PubMed ID: 30415641
[TBL] [Abstract][Full Text] [Related]
17. Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations.
Källén BA; Otterblad Olausson P
Birth Defects Res A Clin Mol Teratol; 2007 Apr; 79(4):301-8. PubMed ID: 17216624
[TBL] [Abstract][Full Text] [Related]
18. Risk of vaginal bleeding and postpartum hemorrhage after use of antidepressants in pregnancy: a study from the Norwegian Mother and Child Cohort Study.
Lupattelli A; Spigset O; Koren G; Nordeng H
J Clin Psychopharmacol; 2014 Feb; 34(1):143-8. PubMed ID: 24135843
[TBL] [Abstract][Full Text] [Related]
19. Risk of preeclampsia after gestational exposure to selective serotonin reuptake inhibitors and other antidepressants: A study from The Norwegian Mother and Child Cohort Study.
Lupattelli A; Wood M; Lapane K; Spigset O; Nordeng H
Pharmacoepidemiol Drug Saf; 2017 Oct; 26(10):1266-1276. PubMed ID: 28815791
[TBL] [Abstract][Full Text] [Related]
20. Antidepressant use during early pregnancy and the risk of congenital anomalies.
Vasilakis-Scaramozza C; Aschengrau A; Cabral H; Jick SS
Pharmacotherapy; 2013 Jul; 33(7):693-700. PubMed ID: 23744675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
